Abbott offers to lower price of antiretroviral Kaletra in Thailand
Published: 2007-04-30 06:59:00
Updated: 2007-04-30 06:59:00
Abbott Laboratories agreed in principle to lower the price of its antiretroviral drug Kaletra in response to Thailand's announcement in January that it would issue a compulsory license for the drug, according to an official at Abbott Korea.
The official said on April 26 that the two sides agre...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
